Table 1 Variants in FGR cases with UPD detected by NIPT, CMA, WES, and CNV-seq.

From: Contribution of uniparental disomy to fetal growth restriction: a whole-exome sequencing series in a prenatal setting

Patient

Chr

Type of UPD

Parental origin

NIPT

WES clinical significance

CMA

Placenta CNV-seq/CMA

Clinical features

P1

15

Segmental iUPD

with hUPD

Maternal

High risk of trisomy 15

Prader-Willi syndrome

arr[hg19] 15q21.3q26.1(51,970,001_89370001) × 2 hmz

NA

Intrauterine growth retardation、Fetal distress

P2

15

iUPD

Maternal

High risk of trisomy 15

Prader-Willi syndrome

arr[hg19]15q11.2q26.3(22,817,871_102,397,317) × 2 hmz

seq[hg19] dup(15) × 2–3

Intrauterine growth retardation

P3

6

iUPD

Maternal

High risk of trisomy 6

NM_014780.5(CUL7):c.509 T > G(p.Leu170Trp)

(Uncertain significance)

arr(6) × 2 hmz

seq[hg19] dup(6) × 2 ~ 3

Intrauterine growth retardation

P4

6

Segmental iUPD

with hUPD

Maternal

High risk of trisomy 6

Uncertain

arr[hg19] 6p25.3p23(203,878_13,411,320) × 2 hmz,

6p21.1p11.1(41,305,454_58,726,706) × 2 hmz,

6q11.1q14.1(61,972,918_75,972,465) × 2 hmz,

6q22.31q25.1(123,041,062_149,830,858) × 2 hmz

seq[hg19] (1–22) × 2,(XN) × 1

Intrauterine growth retardation, Fetal distress, Oligohydramnios

P5

2

Segmental iUPD

with hUPD

Maternal

High risk of Trisomy 2

Uncertain

arr[hg19] 2p25.3p24.3(50,814_13,311,915) × 2 hmz,

2p21p11.2(45,974,85_87,053,152) × 2 hmz,

2q11.1q12.3(95,550,958_109,626,929) × 2 hmz

2q32.3q36.3(192,341,274_230,205,775) × 2 hmz

seq[hg19] dup(2) × 3

Oligohydramnios, Abnormality of calvarial morphology, Stillbirth

  1. NA: not available.